More Alzheimer’s drugs head for FDA review: What scientists are watching
PIK Professor Ezekiel Emanuel called for faster access to data from the trials of drugs designed to treat Alzheimer’s disease.
・ From Nature
PIK Professor Ezekiel Emanuel called for faster access to data from the trials of drugs designed to treat Alzheimer’s disease.
・ From Nature